Produção Nacional
Revisado por pares
Thiabendazole for the Treatment of Strongyloidiasis in Patients with Hematologic Malignancies
2000; Oxford University Press; Volume: 31; Issue: 3 Linguagem: Inglês
10.1086/314023
ISSN1537-6591
AutoresRony Schaffel, Márcio Nucci, Rodrigo Portugal, Marcia B. Castro, Selma Baía Ferreira, Leandro Almeida, Nelson Spector, Wolmar Pulcheri,
Tópico(s)Helminth infection and control
ResumoA total of 21 patients with hematologic malignancies were given thiabendazole for treatment of strongyloidiasis. Fifteen patients were cured. Since there were no relapses, it is unlikely that maintenance therapy has a role in the management of strongyloidiasis in this population of patients.
Referência(s)